KR101929973B1 - 삼당류 유도체 및 이의 보조제로서의 용도 - Google Patents

삼당류 유도체 및 이의 보조제로서의 용도 Download PDF

Info

Publication number
KR101929973B1
KR101929973B1 KR1020137000623A KR20137000623A KR101929973B1 KR 101929973 B1 KR101929973 B1 KR 101929973B1 KR 1020137000623 A KR1020137000623 A KR 1020137000623A KR 20137000623 A KR20137000623 A KR 20137000623A KR 101929973 B1 KR101929973 B1 KR 101929973B1
Authority
KR
South Korea
Prior art keywords
fatty acid
trisaccharide
delete delete
ester
raffinose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020137000623A
Other languages
English (en)
Korean (ko)
Other versions
KR20130056273A (ko
Inventor
요하네스 게르나르두스 마시아스 마리에 반 브리
에베라르두스 요안네스 피터 마리아 스켄켈라스
요베르트 안네 투르크스트라
마리아 알데곤다 자코바 크리에크
로버트 패트릭 호프
빌헬무스 마르티누스 마리아 세아퍼
Original Assignee
이뮤노보 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이뮤노보 비.브이. filed Critical 이뮤노보 비.브이.
Publication of KR20130056273A publication Critical patent/KR20130056273A/ko
Application granted granted Critical
Publication of KR101929973B1 publication Critical patent/KR101929973B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
KR1020137000623A 2010-06-11 2011-06-03 삼당류 유도체 및 이의 보조제로서의 용도 Expired - Fee Related KR101929973B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707.0 2010-06-11
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (2)

Publication Number Publication Date
KR20130056273A KR20130056273A (ko) 2013-05-29
KR101929973B1 true KR101929973B1 (ko) 2018-12-18

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137000623A Expired - Fee Related KR101929973B1 (ko) 2010-06-11 2011-06-03 삼당류 유도체 및 이의 보조제로서의 용도

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033853A2 (en) * 1997-12-23 1999-07-08 Quadrant Holdings Cambridge Limited Carbohydrates, useful in solid delivery systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
FI970867A7 (fi) * 1994-08-04 1997-04-08 Quadrant Drug Delivery Ltd Kiinteät, annostelusysteemit hallittua vapautumista varten, joihin sys teemeihin molekyylit on sisällytetty ja menetelmät niiden valmistamise ksi
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
EP1792607B1 (en) * 2005-12-01 2008-10-01 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
US9242010B2 (en) * 2008-05-16 2016-01-26 Research Foundation Of The City University Of New York Living copolymer-protein/peptide hybrids for biomedical applications
WO2010087207A1 (ja) * 2009-02-02 2010-08-05 大塚化学株式会社 低分子量多硫酸化ヒアルロン酸誘導体及びこれを含有する医薬
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033853A2 (en) * 1997-12-23 1999-07-08 Quadrant Holdings Cambridge Limited Carbohydrates, useful in solid delivery systems

Also Published As

Publication number Publication date
CN103154013A (zh) 2013-06-12
US20130273082A1 (en) 2013-10-17
CN103154013B (zh) 2017-03-15
ES2654156T3 (es) 2018-02-12
EP2397484A1 (en) 2011-12-21
MX2012014422A (es) 2013-08-27
RU2013100945A (ru) 2014-07-20
ZA201209395B (en) 2014-05-28
PT2580226T (pt) 2018-01-05
EP2580226A1 (en) 2013-04-17
IL223570A (en) 2017-03-30
HUE035187T2 (hu) 2018-05-02
HRP20171947T1 (hr) 2018-02-23
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
CY1119704T1 (el) 2018-06-27
MX342946B (es) 2016-10-18
CA2802023A1 (en) 2011-12-15
DK2580226T3 (en) 2018-01-08
JP2016216471A (ja) 2016-12-22
JP2013528211A (ja) 2013-07-08
RU2595717C2 (ru) 2016-08-27
KR20130056273A (ko) 2013-05-29
RS56690B1 (sr) 2018-03-30
PL2580226T3 (pl) 2018-05-30
AU2011262606B2 (en) 2016-10-27
US9327020B2 (en) 2016-05-03
WO2011155822A1 (en) 2011-12-15
EP3312188A1 (en) 2018-04-25
CA2802023C (en) 2020-07-14
NO2580226T3 (enExample) 2018-04-28
US20170057987A1 (en) 2017-03-02
LT2580226T (lt) 2018-02-26
JP6004586B2 (ja) 2016-10-12
SMT201700603T1 (it) 2018-03-08
BR112012031440A2 (pt) 2017-04-18
EP2580226B1 (en) 2017-11-29

Similar Documents

Publication Publication Date Title
JP4164361B2 (ja) 増強した免疫応答を有するワクチン、およびその調製方法
TWI359025B (en) Stabilized synthetic immunogen delivery systems
US20080187553A1 (en) Immunstimulating lipid formulation
EP2271661B1 (en) Derivatives of muramylpeptide
JPS60105630A (ja) ポリオキシプロピレン−ポリオキシエチレンブロツク重合体を基礎とするアジユバント
AU771205B2 (en) Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
KR101929973B1 (ko) 삼당류 유도체 및 이의 보조제로서의 용도
EP2109459B1 (en) Archaeal polar lipid aggregates for administration to animals
Blom et al. Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition
US20060292163A1 (en) Phytol derived immunoadjuvants and their use in vaccine formulations
US20230102247A1 (en) Methods and compositions relating to ionic liquid adjuvants
CN114366810A (zh) 一种可高效诱导体液和细胞免疫的天然微生物和植物来源复合双佐剂及其制备方法和应用
JP4842430B2 (ja) 新規ワクチン組成物及び界面活性剤の免疫用アジュバントとしての使用
KR100904226B1 (ko) 레시틴 유사유화제를 함유하는 나노좀 형태의 면역증강제및 그의 백신용 조성물
KR20230129477A (ko) 글리코알케올 및 면역자극제를 포함하는 아쥬반트
JP2019202957A (ja) 免疫組成物
IL260639B2 (en) Amyloid conjugate and its uses and methods
BR112018016016B1 (pt) Composição farmacêutica compreendendo um conjugado de um ou mais peptídeos cysab (33-40) (seq id no: 1) ligado à hemocianina do molusco keyhole limpet (klh), seu uso, seu método de produção, e ampola de vidro

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20211212

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20211212